Fact-checked by Grok 2 weeks ago

Banisteriopsis caapi

Banisteriopsis caapi is a perennial liana in the family Malpighiaceae, characterized by woody stems that can reach up to 30 meters in length, twining around supporting vegetation in rainforest habitats.^[1] Native to the wet tropical biomes of northern and western South America, including Brazil, Bolivia, Peru, Colombia, Ecuador, and Venezuela, it thrives in lowland Amazonian rainforests at elevations from 100 to 2200 meters.^[2] The plant produces opposite, elliptical leaves and small, clustered flowers, but it is most renowned for its ethnobotanical role as the primary ingredient in ayahuasca, a decoction used by indigenous Amazonian peoples for ritualistic, visionary, and therapeutic purposes.^[3] The vine's stems contain beta-carboline alkaloids, predominantly harmine (0.31–8.43%), harmaline (0.03–0.83%), and tetrahydroharmine (0.05–2.94%), which function as reversible monoamine oxidase inhibitors (MAOIs), potentiating the psychoactive effects of N,N-dimethyltryptamine (DMT) from co-administered plants like Psychotria viridis.^[4] These compounds contribute to ayahuasca's pharmacological profile, inducing altered states of consciousness through serotonin receptor agonism and neurotransmitter modulation, with empirical studies indicating potential neuroprotective and antidepressant effects.^[5] While traditional use spans millennia among groups such as the Shipibo and Asháninka, contemporary research explores its applications in treating substance dependence and neurological disorders, though legal restrictions in many jurisdictions stem from its association with hallucinogenic experiences rather than inherent toxicity.^[6] Cultivation outside native ranges has increased due to global interest in ayahuasca analogs, but sustainability concerns arise from overharvesting in wild populations.^[7]

Botanical and Taxonomic Characteristics

Description and Morphology

Banisteriopsis caapi is a perennial climbing liana in the family Malpighiaceae, distinguished by its woody, twining stems that extend up to 30 meters in length, enabling it to ascend forest canopies by coiling around supporting trees.^[8] The stems develop a robust, often braided structure that provides mechanical support for vertical growth in dense tropical environments.^[9] Leaves are arranged oppositely along the stems, elliptical to ovate in shape, with entire margins, measuring 8–18 cm long and 3.5–8 cm wide, and featuring a glabrous upper surface.^[10] Inflorescences consist of small flowers borne in axillary or terminal panicles, with petals exhibiting a pinkish hue and blooming sporadically.^[10]^[11] Key morphological adaptations for its habitat include the twining growth habit, which facilitates efficient resource capture in light-limited understories by reaching upper strata, and the lignified stems that endure physical stresses from wind and host movement.^[8] These features underscore its specialization as a hemiepiphytic climber in humid, lowland tropical forests.^[2]

Habitat, Distribution, and Ecology

Banisteriopsis caapi is native to the tropical rainforests of the Amazon basin in South America, with confirmed occurrences in Peru, Brazil, Colombia, and extending to other countries in southern tropical America.^[12]^[13] It thrives as a woody, evergreen liana in wet tropical biomes, characteristically climbing host trees in shaded, moist understory habitats of lowland rainforests.^[14] The plant's smooth brown bark and large, dark green, pointed leaves adapt it to the humid, low-light conditions prevalent in these ecosystems.^[15] Phylogenetic analyses indicate that the genus Banisteriopsis originated during the Miocene epoch around 22 million years ago, with subsequent diversification linked to the expansion of dry forest habitats across South America.^[13] However, B. caapi specifically occupies the humid northwestern Amazon region, representing an adaptation within the genus to persistently wet environments rather than drier savanna-like conditions.^[13] This evolutionary history underscores its deep-rooted presence in neotropical forest dynamics. Ecologically, B. caapi functions as a hemiepiphytic climber, integrating into the vertical stratification of rainforest canopies by twining around taller trees for structural support, thereby influencing light competition and microhabitat formation.^[16] As a liana, it contributes to forest connectivity and biodiversity by providing habitat corridors and resources within the understory layer.^[17] Detailed studies on its pollination and seed dispersal in natural populations are lacking, though general patterns in the Malpighiaceae family suggest potential reliance on specialized insect vectors for reproduction.^[14]

Chemical Constituents

Primary Alkaloids

The primary alkaloids in Banisteriopsis caapi are the β-carboline compounds harmine, harmaline, and tetrahydroharmine (THH), which are concentrated primarily in the vine's stems and constitute the plant's dominant psychoactive phytochemicals.^[18] These tricyclic indole alkaloids were first isolated from B. caapi extracts in the mid-20th century through solvent extraction and chromatographic separation, with harmine identified as the principal component due to its prevalence in empirical assays.^[19] Structurally, harmine and harmaline feature a methylated tryptoline core with a pyridine ring, differing in saturation levels—harmine being fully aromatic, harmaline partially reduced, and THH fully saturated at the pyridine moiety—conferring distinct physicochemical properties such as varying solubility and UV absorbance used in their detection. Quantification studies report total β-carboline content averaging 0.4% of dry stem weight, with ranges from 0.05% to 1.95% across samples; harmine typically dominates at 0.3–8.4 mg/g dry weight (0.03–0.84%), harmaline at lower levels (0.03–0.83 mg/g), and THH varying comparably but often trailing harmine in abundance.^[18] Alkaloid profiles exhibit significant variability influenced by factors including plant maturity (higher in older vines), harvest season (elevated during dry periods), genetic cultivar differences, and post-harvest processing such as drying methods, which can degrade labile compounds like harmaline if exposure to heat or light is excessive.^[19]^[20] Extraction techniques, from traditional aqueous decoction to modern acid-base methods, further modulate yields, with acidic conditions optimizing β-carboline solubility while minimizing co-extraction of tannins.^[21] Analytical quantification relies on high-performance liquid chromatography (HPLC) coupled to ultraviolet (UV) or mass spectrometry (MS) detection, enabling separation and precise measurement of these alkaloids in plant matrices; for instance, reversed-phase HPLC with electrospray ionization MS/MS achieves limits of detection below 0.1 µg/mL for harmine and congeners.^[22]^[23] Gas chromatography-mass spectrometry (GC-MS) serves as an alternative for volatile derivatives but is less favored due to potential thermal decomposition of THH.^[19] These methods confirm the alkaloids' structural integrity and concentration heterogeneity, underscoring the need for standardized protocols in phytochemical profiling to account for environmental and preparative variances.^[24]

Secondary Metabolites

Phytochemical profiling of Banisteriopsis caapi reveals a range of non-alkaloidal secondary metabolites, including flavonoids such as rutin, isoquercetin, and epicatechin, as well as procyanidin B1, a type of proanthocyanidin. These compounds, identified through LC-MS analysis of vine extracts, contribute to the plant's chemical diversity alongside its dominant β-carboline alkaloids. Terpenoids, phenols, tannins, saponins, and steroids have also been detected via histochemical and screening methods, underscoring the vine's broad secondary metabolome.^[25] In plant physiology, these metabolites likely serve protective roles, such as scavenging reactive oxygen species to mitigate oxidative stress from environmental factors like UV radiation and pathogens, with flavonoids and proanthocyanidins acting as antioxidants and structural reinforcers in vascular tissues. Polyphenolic fractions, including phenolic acids and glycosylated flavonoids derived from quercetin (e.g., rutin and isoquercetin), exhibit potential for stabilizing alkaloid content during decoction processes, suggesting synergistic interactions that enhance overall extract stability without altering primary alkaloid profiles. Extraction yields of these non-alkaloids vary by solvent, with aqueous methods recovering measurable polyphenolic loads, though quantitative data remain limited compared to alkaloid assays.^[26] Trace non-alkaloidal indoles and resinous phenolics have been noted in stem profiling, potentially influencing metabolite synergy by modulating solubility and bioavailability in traditional preparations, though their physiological roles in B. caapi require further empirical validation.^[19] Overall, these secondary metabolites bolster the vine's resilience in Amazonian habitats, where they may interact causally with primary defenses to optimize resource allocation under fluctuating ecological pressures.

Traditional Uses

In Amazonian Indigenous Cultures

Indigenous groups in the western Amazon, such as the Shipibo-Conibo and Asháninka, incorporate Banisteriopsis caapi into ethnomedical practices for treating ailments and facilitating spiritual insights, with field inventories documenting its role alongside other lianas in pharmacopoeias.^[27]^[28] Among the Awajún of northern Peru, the vine is traditionally decocted alone as purgahuasca—distinct from the more visionary ayahuasca blend—for initiatory rites marking shamanic training and addressing conditions like drug dependency, as observed in community-based studies.^[29]^[30] Ethnographic records indicate solo use of the vine predominates in some isolated contexts for purgative and introspective effects, while admixtures with Psychotria viridis or similar plants amplify visionary components, though the vine's beta-carboline alkaloids remain central regardless.^[31] The vine's deployment serves initiatory, divinatory, and curative functions, often administered by specialists to diagnose illnesses attributed to spiritual imbalances, with usage patterns varying by ethnic group—e.g., more frequent in Shipibo ceremonial healing than in Asháninka daily remedies.^[27]^[28] While oral histories and linguistic distributions imply pre-Columbian origins, direct archaeological or paleobotanical evidence remains elusive, rendering claims of extreme antiquity speculative despite the vine's integration into diverse Amazonian cosmologies.^[31]^[32] Contemporary non-indigenous adaptations, including ayahuasca tourism, have drawn scholarly critique for constituting cultural appropriation, as Western participants often extract rituals from their socio-ecological moorings, commodifying indigenous expertise without reciprocal benefits or authentic transmission.^[33]^[34] Such practices risk perpetuating inequities, with reports of opportunistic "shamans" exploiting tourists while eroding traditional authority structures among originating communities.^[35] Many attendant shamanic assertions—e.g., of supernatural diagnostics or entity communications—lack independent verification, relying instead on unverifiable subjective testimonies that field anthropologists approach with caution due to observer bias and cultural translation challenges.^[36]^[31]

Preparation and Rituals

Traditional preparation of Banisteriopsis caapi involves shredding or pounding the vine's stems and boiling them in water, typically combined with admixtures such as leaves of Psychotria viridis to form ayahuasca, a decoction used in indigenous Amazonian practices.^[37] The process requires prolonged simmering, often lasting 10-12 hours or more per batch, with multiple reductions over several days to concentrate the alkaloids and achieve a viscous consistency; fresh water is added iteratively to extract compounds fully.^[38] Over 100 plant species have been documented as potential additives across regions, varying by healer intent and local availability, which can alter the brew's composition and potency.^[9] In ceremonial contexts among tribes like the Shipibo-Conibo and Shuar, the brew is administered under shamanic guidance, often at night in malocas (communal huts), with rituals incorporating icaros (healing songs), tobacco smoke for purification, and purging as a cleansing element.^[9] ^[37] Participants typically follow pre-ceremony fasting or strict dietary protocols, avoiding heavy foods, salt, and stimulants for hours or days prior to enhance receptivity and minimize interactions, though adherence varies by tradition.^[39] Dosages range from 20-30 ml in Shuar practices to larger volumes in others, administered in 2-3 servings per session, with the shaman determining amounts based on experience and participant needs.^[9] Practices differ across Amazonian groups; for instance, some Asháninka or Shipibo shamans consume the brew solo for divination and diagnosis, while communal use occurs for healing or conflict resolution, potentially incorporating plants like Brugmansia for intensified visions.^[37] These variations, reliant on oral transmission and local ecology, can introduce risks of contamination or inconsistent alkaloid levels if admixtures are misidentified or preparation shortcuts taken by less experienced preparers.^[9]

Pharmacological Properties

Monoamine Oxidase Inhibition

The β-carboline alkaloids harmine, harmaline, and tetrahydroharmine extracted from Banisteriopsis caapi stems primarily exert their biochemical effects through reversible competitive inhibition of monoamine oxidase A (MAO-A), an enzyme responsible for the oxidative deamination of monoamines such as serotonin, norepinephrine, and exogenous tryptamines like N,N-dimethyltryptamine (DMT).^[40] This inhibition follows standard enzyme kinetics, where the alkaloids bind non-covalently to the enzyme's flavin adenine dinucleotide (FAD) cofactor site, increasing the apparent K_m for substrates without altering V_max, thereby reducing substrate breakdown in a concentration-dependent manner as long as inhibitor levels remain sufficient.^[41] Unlike irreversible inhibitors that require enzyme resynthesis (with MAO-A turnover half-life estimated at 30-40 days in humans), the reversible nature allows recovery within hours, tied to the alkaloids' pharmacokinetics rather than de novo protein synthesis.^[40] Harmine demonstrates the highest potency among these, with reported IC₅₀ values for MAO-A ranging from 2-5 nM in recombinant human enzyme assays and rat liver homogenates, reflecting tight binding affinity (K_i ≈ 1-3 nM).^[42]^[41] Harmaline shows comparable nanomolar potency (IC₅₀ ≈ 2.5-5 nM), while tetrahydroharmine is weaker (IC₅₀ in the micromolar range), contributing less to overall inhibition but potentially modulating via reduction to active forms in vivo.^[43] These values indicate greater potency than many synthetic reversible MAOIs, such as moclobemide (IC₅₀ ≈ 200-400 nM for MAO-A), enabling effective gastrointestinal and hepatic inhibition at lower doses to enhance oral bioavailability of otherwise rapidly metabolized substrates like DMT, which has negligible oral activity without MAO blockade.^[40] Selectivity favors MAO-A over MAO-B by 50-100-fold, minimizing phenethylamine-related effects while targeting serotoninergic pathways, as confirmed in isoform-specific recombinant assays.^[44] In vitro studies using human and rodent liver microsomes demonstrate 80-95% MAO-A inhibition at pharmacologically relevant concentrations (10-100 nM harmine equivalents), with linearity in Lineweaver-Burk plots confirming competitive kinetics.^[45] Animal models, including intraperitoneal administration in rats, reveal peak inhibition within 30-60 minutes, sustaining 70-90% MAO-A blockade for 4-6 hours before declining with plasma clearance (harmine half-life ≈ 1-2 hours), allowing transient elevation of monoamine levels without prolonged tyramine sensitivity risks associated with irreversible agents.^[42] This duration aligns with observed deamination blockade in ex vivo tissue assays, where preincubation with B. caapi extracts preserved substrate integrity comparably to synthetic benchmarks but with faster reversibility.^[45]

Neurotransmitter Interactions

The primary alkaloids in Banisteriopsis caapi, such as harmine and harmaline, exhibit modest binding affinity to serotonin 5-HT_2A and 5-HT_1A receptors, with potency influenced by structural substituents on the beta-carboline scaffold; this binding activates G-protein-coupled signaling cascades, including phospholipase C activation via 5-HT_2A, leading to inositol trisphosphate production and intracellular calcium mobilization in recombinant cell lines.^[46] Harmaline further modulates these pathways by direct interaction at receptor sites, independent of monoamine oxidase inhibition, as evidenced by its persistence in receptor assays under enzymatic blockade conditions.^[46] These compounds also influence dopaminergic systems through augmentation of evoked dopamine efflux in striatal slices, interacting with targets such as trace amine-associated receptor 1 (TAAR1) and dopamine transporters, which enhance vesicular release via cAMP-dependent phosphorylation of synapsin proteins in vitro.^[47] Tetrahydroharmine, a reduced beta-carboline, similarly modulates trace amine levels, promoting downstream D2 receptor signaling without altering baseline dopamine tone in isolated neuronal cultures.^[47] Harmaline and related beta-carbolines stimulate locus coeruleus noradrenergic neurons via imidazoline I₂ receptor agonism, increasing firing rates and noradrenaline release through inhibition of monoamine oxidases and enhancement of hyperpolarization-activated cyclic nucleotide-gated channels, as demonstrated in anesthetized rat brainstem slices.^[48] In vitro studies reveal harmine's promotion of neurogenesis in human neural progenitor cells through dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibition, which upregulates brain-derived neurotrophic factor (BDNF) expression via stabilization of beta-catenin and activation of CREB-dependent transcription, resulting in increased proliferation and differentiation markers like Nestin and NeuroD in cell cultures.^[49] Harmaline and tetrahydroharmine contribute analogously by modulating adult neural stem cell activity in hippocampal-derived lines, fostering TrkB receptor autophosphorylation and downstream MAPK/ERK cascades for neuronal maturation.^[4]

Effects on Humans

Acute Physiological Effects

Ingestion of Banisteriopsis caapi vine preparations, typically involving decoctions of 50-100 grams of dried stem bark, commonly induces acute gastrointestinal effects including nausea, vomiting, and diarrhea, collectively termed "purging" in traditional contexts.^[29] These effects occur in approximately 53% of users in observational settings with caapi alone and are attributed to the serotonergic activity of its primary alkaloids, harmine and harmaline, which act as agonists at peripheral serotonin receptors and inhibit monoamine oxidase A (MAO-A), elevating endogenous serotonin levels in the gut.^[50] Mechanisms may also involve direct central nervous system stimulation or intestinal MAO inhibition, though exact pathways remain incompletely elucidated in human studies.^[50] Cardiovascular responses to B. caapi alkaloids include mild, transient elevations in blood pressure and heart rate, observed in controlled administrations of beta-carboline-containing brews equivalent to caapi extracts. For instance, doses delivering approximately 25-35 mg of harmine result in diastolic blood pressure increases of up to 9 mm Hg peaking around 75 minutes post-ingestion, with moderate systolic pressure and heart rate rises that resolve within 2-4 hours.^[51] These changes are dose-dependent and generally sub-clinical in healthy individuals, reflecting sympathetic activation via MAO-A inhibition and subsequent catecholamine modulation, without evidence of sustained hypertension in short-term use.^[51]^[52] Pharmacokinetic profiles of caapi's key alkaloids show rapid oral absorption following decoction ingestion, with harmine reaching peak plasma concentrations of 50-100 ng/mL within 1-2 hours, influenced by the vine's alkaloid content (typically 0.5-1.7% harmine by dry weight).^[53] Harmaline exhibits similar kinetics but faster elimination, contributing to the acute phase's brevity, while tetrahydroharmine persists longer due to slower metabolism.^[53] Variability arises from preparation methods, with higher doses (e.g., equivalent to 100-200 g fresh vine) intensifying physiological responses, though individual factors like body weight and fasting state modulate onset and intensity.^[29]

Psychological Experiences and Risks

Consumption of Banisteriopsis caapi alone or as part of ayahuasca brews induces subjective psychological experiences characterized by altered perception, vivid visual imagery, and sensations of ego dissolution or oceanic boundlessness in some users. These effects stem from the beta-carboline alkaloids harmine and harmaline, which modulate serotonin systems, including partial agonism at 5-HT2A receptors, leading to introspective states and potential short-term reductions in anxiety through enhanced neural plasticity and divergent thinking.^[54]^[55] However, such reports derive largely from anecdotal ethnobotanical accounts and uncontrolled user surveys, with early investigations from the 1950s to 1970s, such as those documenting indigenous rituals, lacking rigorous controls and prone to expectancy biases.^[56] Placebo-controlled studies reveal high variability in outcomes, where ayahuasca containing B. caapi produced rapid antidepressant effects superior to placebo in treatment-resistant depression, yet psychological flexibility and creativity enhancements were influenced by set and setting factors, underscoring non-pharmacological contributors like ritual context over universal pharmacological causality.^[57]^[58] Claims of profound spiritual healing or ego transcendence, often amplified in popular narratives, overlook individual predispositions such as prior mental health history, which correlate with inconsistent responses including heightened emotional intensity without guaranteed long-term resolution.^[59] Risks include acute psychological distress, such as agitation, paranoia, or intensified hallucinations, reported in up to 56% of users experiencing negative mental health impacts post-consumption, particularly among those with preexisting anxiety or depression.^[52]^[60] Global surveys indicate challenging experiences like emotional purging or fear states occur frequently but resolve without intervention in most cases; however, vulnerability to exacerbation of latent psychiatric conditions persists, with harmaline's tremor-inducing properties potentially amplifying disorientation.^[61] Empirical data from observational cohorts emphasize that while short-term insights may occur, overhyped notions of transformative universality ignore placebo influences and the absence of consistent causal links to enduring psychological benefits across diverse populations.^[52]^[62]

Scientific Research and Therapeutic Potential

Historical Studies

The English botanist Richard Spruce first documented Banisteriopsis caapi during his expedition along the Rio Uaupés in Brazil in 1851, collecting specimens and noting its use by indigenous Tukanoan groups to prepare a hallucinogenic decoction for prophetic purposes.^[63] Spruce classified it initially as Banisteria caapi, a name later revised to Banisteriopsis caapi based on morphological distinctions within the Malpighiaceae family.^[63] His observations, published posthumously in 1908, marked the initial Western scientific encounter with the vine, though pharmacological analysis of samples remained limited due to incomplete preservation and lack of chemical tools at the time.^[64] In the mid-20th century, ethnobotanist Richard Evans Schultes advanced understanding through fieldwork in the Colombian Amazon starting in 1941, where he cataloged multiple cultivars of B. caapi used by Witoto and Bora peoples in ayahuasca preparations, emphasizing variations in alkaloid content tied to ritual efficacy.^[65] Schultes' expeditions, spanning the 1940s and 1950s, involved direct participation in ceremonies and collection of over 2,000 plant specimens, highlighting the vine's role in shamanic divination but relying heavily on indigenous informants without quantitative biochemical assays.^[66] These descriptive studies, disseminated in publications like The Plants of the Gods (co-authored later), laid groundwork for recognizing B. caapi's beta-carboline alkaloids—harmine, harmaline, and tetrahydroharmine—but were constrained by small observational samples and cultural interpretive biases.^[64] Early pharmacological investigations in the 1920s and 1930s focused on extracts from B. caapi for potential antiparkinsonian effects, building on harmine's prior isolation from related sources and its demonstrated monoamine oxidase inhibition in animal models.^[64] Preliminary human administrations in South American clinics, often combined with other plants, reported motor improvements in encephalitis lethargica patients, yet lacked placebo controls and dose standardization, confounding results with subjective reports.^[64] By the 1960s–1990s, anthropologists like Luis Eduardo Luna extended ethnobotanical inquiry among Peruvian mestizo healers, documenting B. caapi's solo use for visionary states in vegetalismo traditions, but these qualitative accounts similarly suffered from uncontrolled variables, including variable alkaloid potency and participant expectations influenced by ritual contexts.^[67] Overall, pre-2000 studies prioritized cultural documentation over rigorous experimentation, revealing gaps in replicability due to heterogeneous preparations and minimal blinding.^[64]

Recent Clinical Trials and Findings

A 2019 randomized, double-blind, placebo-controlled trial involving 29 patients with treatment-resistant depression found that a single dose of ayahuasca led to significant reductions in depression severity scores within 1 week, with effects persisting up to 21 days, outperforming placebo on the Hamilton Depression Rating Scale.^[68] Neuroimaging studies from 2015 onward have linked these antidepressant outcomes to ayahuasca's disruption of the default mode network (DMN), reducing its activity and connectivity, which correlates with decreased rumination and self-referential thinking.^[69] A 2023 systematic review of neuroimaging data confirmed consistent DMN modulation across ayahuasca sessions, supporting short-term therapeutic potential but noting variability due to ritual contexts.^[70] For substance use disorders, results remain mixed; a 2024 observational study following 96 participants post-ayahuasca retreat reported reduced substance use severity and improved mental wellness at 1-year follow-up, but lacked randomization and controls.^[71] Small-scale retreat-based research, such as a 2025 analysis of 12 individuals, indicated psychological benefits alongside lower substance cravings, yet emphasized the need for larger controlled trials due to confounding ceremonial factors.^[72] A 2025 non-randomized, open-label trial on grief (n=51 bereaved adults) demonstrated ayahuasca-assisted meaning reconstruction therapy reduced prolonged grief disorder symptoms by 40-50% post-intervention, with sustained effects at 6 months, though self-reported outcomes and absence of blinding limit causal inference.^[73] Physiologically based pharmacokinetic (PBPK) modeling advanced in 2025, linking harmine from B. caapi with N,N-dimethyltryptamine (DMT) to predict plasma concentrations, informing safer dosing regimens and reducing variability in therapeutic exposure across individuals.^[74] Evidence for anti-inflammatory effects remains preclinical; no large human trials confirm efficacy for conditions like stroke recovery, with 2025 rodent studies on B. caapi extracts suggesting neuroinflammatory modulation but untested clinically.^[75] Despite promising signals, evidential weaknesses persist: most trials feature small samples (often n<50), open-label designs vulnerable to expectancy bias, and inconsistent blinding, inflating perceived benefits.^[76] Publication bias favors positive outcomes, with few negative or null results reported, and long-term efficacy data scarce beyond 6-12 months; randomized, adequately powered studies are urgently needed to substantiate claims.^[77]

Health Risks and Safety Concerns

Adverse Reactions

Consumption of Banisteriopsis caapi-containing preparations, such as ayahuasca, commonly induces acute gastrointestinal adverse reactions including nausea and vomiting, reported in up to 69.9% of users in observational surveys.^[52] These effects are attributed to the emetic properties of beta-carboline alkaloids like harmine and harmaline, which act as reversible monoamine oxidase inhibitors (MAOIs), potentially exacerbating gut motility disruptions.^[78] Diarrhea and abdominal discomfort frequently accompany these symptoms, with approximately 2.3% of participants requiring subsequent medical evaluation for persistent physical distress.^[52] Neurological adverse reactions, including seizures and acute psychosis, have been documented in case reports, particularly among individuals with predisposing psychiatric vulnerabilities or high-dose ingestion.^[79] For instance, a 2021 case described a psychotic episode with hallucinations and delusions following ayahuasca intake, resolving with antipsychotic treatment but highlighting risks in those with schizophrenia history.^[80] Seizures may arise from excessive serotonergic activity due to MAOI-mediated inhibition of dimethyltryptamine (DMT) breakdown when co-ingested, though empirical incidence remains low outside controlled settings.^[81] Pharmacokinetic interactions pose significant acute risks, notably serotonin syndrome when combined with selective serotonin reuptake inhibitors (SSRIs) or other serotonergics, manifesting as hyperthermia, myoclonus, and autonomic instability.^[82] Case reports confirm this toxicity, with symptoms like agitation and tachycardia in users concurrently on antidepressants, underscoring contraindications for those on such medications.^[83] Similarly, tyramine-rich foods can precipitate hypertensive crises via MAO-A inhibition, elevating catecholamine levels and risking cardiovascular events in susceptible individuals.^[78] Poison control data indicate rare but severe emergency department presentations, often linked to polydrug use or underlying conditions rather than isolated B. caapi overdose.^[84] Fatalities are exceptionally rare and typically involve confounding factors like polysubstance intoxication, with insufficient evidence establishing direct causality from B. caapi alkaloids alone.^[82] Vulnerable populations, including those with cardiovascular disease or bipolar disorder, exhibit heightened acute reaction rates compared to placebo in psychedelic trials, though overall toxicity profiles appear milder than opioids based on self-reported harm scales.^[85] Contraindications extend to patients with uncontrolled hypertension or severe hepatic impairment, where MAOI accumulation could amplify adverse outcomes.^[86]

Long-term Effects and Dependencies

A 2025 study utilizing rodent models demonstrated that repeated administration of Banisteriopsis caapi extract at high concentrations led to noradrenergic neuron depletion and induced a proinflammatory state in the brain, raising concerns about potential neuroinflammatory risks from chronic high-dose exposure.^[75] This preclinical evidence contrasts with claims of inherent harmlessness, highlighting mechanisms that could contribute to sustained neuronal stress absent in acute use.^[75] Human data on long-term effects remain limited, with no robust longitudinal randomized trials establishing causality for cognitive decline or structural brain changes from isolated B. caapi consumption.^[87] Observational studies of ayahuasca users, which include B. caapi as the primary MAOI component, report preserved global cognition and no consistent evidence of neuropsychological impairment after years of intermittent use, though self-selected ceremonial participants may underreport issues.^[87]^[88] Gaps persist due to confounding factors like concurrent DMT-containing plants and lifestyle variables in ritual contexts, potentially masking exacerbations of underlying mental health conditions such as latent anxiety or dissociative tendencies.^[60] Physical dependence on B. caapi alkaloids like harmine and harmaline is negligible, with no withdrawal syndrome documented akin to opioids or stimulants, supported by clinical observations in extended users.^[68] Psychological reliance, however, poses risks, particularly in habitual ceremonial settings where users may develop fixation on perceived insights, leading to repeated seeking despite intermittent negative emotional aftereffects reported by up to 56% in post-use surveys.^[89]^[60] Such patterns underscore the need for caution, as ritual frameworks can obscure dependency dynamics not evident in controlled pharmacological assessments.^[88]

Legal and Regulatory Status

International Conventions

The United Nations Convention on Psychotropic Substances, adopted on February 21, 1971, in Vienna, classifies N,N-dimethyltryptamine (DMT)—a key component in some ayahuasca preparations combining Banisteriopsis caapi with DMT-containing plants such as Psychotria viridis—as a Schedule I substance, subjecting it to the strictest controls due to its perceived high potential for abuse and lack of accepted medical use.^[90] However, the convention explicitly excludes plants and natural materials containing controlled substances from international regulation, leaving B. caapi vines and their primary beta-carboline alkaloids (harmine, harmaline, and tetrahydroharmine) unscheduled.^[91]^[92] This plant-substance distinction results in ambiguous application to B. caapi-based decoctions, with signatory nations interpreting the treaty variably: some treat ayahuasca analogs as de facto controlled due to DMT content, while others permit the unregulated vine itself or traditional preparations absent isolated DMT.^[91] The convention's commentary acknowledges ayahuasca's role in Amazonian indigenous rites but prioritizes limiting non-medical psychotropic substance trafficking and use.^[93] No amendments or subsequent UN instruments have scheduled B. caapi or its alkaloids, and the World Health Organization's Expert Committee on Drug Dependence has not recommended their inclusion in controlled schedules despite periodic reviews of psychedelics. This regulatory gap highlights tensions with broader UN frameworks, such as the 2007 Declaration on the Rights of Indigenous Peoples, which affirms indigenous access to traditional medicines and vital plants (Article 24), yet yields to the binding obligations of drug control treaties emphasizing abuse prevention over cultural exemptions.^[94]^[95]

National Variations

In the United States, Banisteriopsis caapi vines are not explicitly listed as a controlled substance under federal law, but ayahuasca preparations incorporating DMT from admixture plants are prohibited due to DMT's Schedule I classification under the Controlled Substances Act.^[96] Religious exemptions apply to specific groups, such as the União do Vegetal church, following a 2006 Supreme Court ruling in Gonzales v. O Centro Espírita Beneficente União do Vegetal, which permitted sacramental use of ayahuasca under the Religious Freedom Restoration Act.^[97] State-level variations include Colorado's Proposition 122, approved by voters on November 8, 2022, which decriminalized personal possession, use, cultivation, and non-commercial sharing of "natural medicines" explicitly encompassing ayahuasca, with enforcement designated as the lowest law enforcement priority.^[98] Oregon's Measure 109, effective from 2021, regulates psilocybin services but leaves ayahuasca subject to federal prohibitions outside religious exemptions, though broader drug decriminalization under Measure 110 (partially repealed in 2024) reduced some misdemeanor penalties without altering psychedelic-specific status.^[99] No federal rescheduling or decriminalization of DMT-containing substances occurred between 2024 and October 2025.^[100] In Brazil, ayahuasca—including Banisteriopsis caapi as the primary ingredient—has been permitted for religious rituals since a 1992 decision by the Conselho Federal de Narcóticos, which classified it outside standard drug controls due to its established role in syncretic churches like Santo Daime and União do Vegetal, with over 100,000 adherents by 2020.^[101] Peru legally recognizes ayahuasca as intangible cultural heritage under Supreme Decree No. 006-2010-PCM (2010), allowing traditional indigenous and mestizo use of B. caapi-based brews without criminal penalties, though commercial exploitation requires oversight by the Ministry of Culture.^[99] Australia prohibits ayahuasca under the Poisons Standard (February 2022 update), listing DMT as a Schedule 9 prohibited substance, which extends to B. caapi preparations and imposes penalties up to 25 years imprisonment for trafficking.^[85] In France, ayahuasca is illegal per a 2010 decree banning DMT-containing substances, with B. caapi vines prosecutable if linked to prohibited brews, resulting in enforcement actions against retreats as recently as 2023.^[102] European Union member states generally align with the 1971 UN Convention on Psychotropic Substances by controlling DMT, leading to bans on ayahuasca importation and use in countries like Germany and the Netherlands, though Spain permits religious exemptions for groups established before 2005.^[103] Importation of Banisteriopsis caapi vines into the US carries risks under the Federal Analogue Act if authorities deem them intended for combination with DMT sources, prompting customs seizures despite the vine's non-scheduled status; documented cases include 2024 detentions at ports for suspected ayahuasca production.^[104] Enforcement remains inconsistent, prioritizing intent over mere possession of the vine.^[105]

Cultivation and Conservation

Propagation Methods

Banisteriopsis caapi is primarily propagated vegetatively via stem cuttings, which root readily without hormones in a moist, well-draining medium such as a 1:1 mix of soil and sand or coco peat, placed in polyethylene bags or pots under high humidity.^[106]^[107] Cuttings should be taken from mature vines as T-shaped sections or semi-softwood segments, often with aerial roots if available, and maintained in a humidity dome with regular misting to promote rooting within weeks.^[108]^[109] Seed propagation is less common due to variable viability but feasible with fresh seeds harvested in October or November; these are soaked in warm water for 24 hours, then sown shallowly in acidic, well-draining potting soil under bottom heat and a germination temperature of 22-28°C.^[110]^[111] Cultivation thrives in humid, acidic soils (pH mildly acid to very acid) that retain moisture yet drain well to prevent root rot, with optimal temperatures of 25-30°C daytime and high relative humidity mimicking Amazonian rainforest conditions.^[112]^[113] In greenhouse environments, vines exhibit growth rates of 2-3 meters per year under filtered light and consistent warmth, supporting both personal-scale pot culture with humidity domes and commercial scaling via trellised rows for vine extension up to 30 meters.^[114]^[115] Key challenges include overwatering-induced rot in cuttings, slow initial establishment in non-tropical settings, and pest susceptibility to general tropical vines such as aphids or fungal pathogens under suboptimal drainage.^[108] Alkaloid yields, primarily harmine and tetrahydroharmine concentrated in roots and stems, vary by cultivar origin and environmental factors, with optimization requiring mature vines (3-5 years) grown in nutrient-rich, shaded conditions to maximize beta-carboline content over 0.5-1.7% dry weight.^[116]^[19]

Sustainability and Overharvesting Issues

The surge in ayahuasca tourism has intensified harvesting pressure on Banisteriopsis caapi populations across the Peruvian and Brazilian Amazon, where vines are selectively cut for their beta-carboline-rich bark. A 2023 ecological study in Peru's Amazon rainforest documented that heavily harvested sites exhibited elevated clonal propagation as a stress response, yet this compensatory mechanism failed to offset declines, projecting a 1.3% annual reduction in population growth rates under sustained high-pressure extraction.^[117] Such localized strains are exacerbated by the vine's perennial liana habit, which demands extended recovery periods post-harvest, with empirical models indicating reduced survival rates for smaller individuals in exploited areas.^[117] As demand escalates—driven by thousands of annual tourists seeking ceremonial brews—harvesters are pushed deeper into intact forests, contributing to secondary biodiversity impacts like habitat fragmentation and deforestation in regions such as Brazil's Acre state.^[118] A 2025 assessment of psychedelic species conservation highlights B. caapi among vines facing overharvesting risks, though it lacks formal IUCN listing; anecdotal reports from indigenous groups, including Shipibo-Conibo shamans, underscore fears of regional scarcity amid export demands to Europe and North America.^[119] ^[120] Cultivation emerges as a debated mitigation strategy, with small-scale commercial plantations increasing in Peru to alleviate wild sourcing, yet critics note potential for expanded deforestation if scaled without regulation.^[121] While the Amazon's vast extent buffers basin-wide extinction risks, localized empirical data affirm vulnerability in high-tourism corridors, prompting calls for sustainable harvest quotas informed by demographic modeling rather than unsubstantiated alarmism.^[15]^[117]

References

[1]
Banisteriopsis caapi - Useful Tropical Plants
General Information. Yage is a large climbing shrub, producing woody stems up to 30 metres long and twining itself round other plants for support. The plant ...
[2]
Banisteriopsis caapi (Spruce ex Griseb.) C.V.Morton
The native range of this species is S. Tropical America. It is a climber and grows primarily in the wet tropical biome. It is used as a medicine and has ...Missing: habitat | Show results with:habitat
[3]
The alkaloids of Banisteriopsis caapi, the plant source of the ...
Jul 13, 2017 · Banisteriopsis caapi is the basic ingredient of ayahuasca, a psychotropic plant tea used in the Amazon for ritual and medicinal purposes, ...
[4]
The alkaloids of Banisteriopsis caapi, the plant source of ... - Nature
Jul 13, 2017 · B. caapi contains high amounts of harmine and tetrahydroharmine (THH) and to a lesser degree harmaline, three indole alkaloids with β-carboline ...
[5]
Components of Banisteriopsis caapi, a Plant Used in the ...
Apr 13, 2022 · Banisteriopsis caapi is used to prepare the psychoactive beverage ayahuasca, and both have therapeutic potential for the treatment of many ...
[6]
Banisteriopsis caapi, a Forgotten Potential Therapy for Parkinson's ...
Oct 6, 2015 · Banisteriopsis caapi, a liana indigenous to the Amazon basin with metagnomigenic properties and possible anti-depressant effects is one of the natural sources ...
[7]
Ethnobotany and Wood Anatomy of Banisteriopsis caapi Ethnotaxa ...
Mar 10, 2023 · Brazilian ayahuascan groups (BAGs) commonly prepare the tea using the stems of Banisteriopsis caapi (Malpighiaceae) along with the leaves of ...
[8]
Banisteriopsis caapi - Useful Tropical Plants
### Summary of Banisteriopsis caapi Morphology
[9]
Ayahuasca: Basic Info | Banisteriopsis caapi | Psycheplants - ICEERS
Some ethnic and religious groups add the Psychotria viridis plant to ayahuasca, which has visionary effects and whose active component is dimethyltryptamine ( ...
[10]
Banisteriopsis caapi - Plant Detail - NTBG Database
Leaves are opposite, oval-shaped, green, marginally entire, 8-18 cm long, 3.5-8 cm wide, upper surface glaborous. The inflorescence is axillary or terminal ...Missing: morphology | Show results with:morphology
[11]
Banisteriopsis caapi (Spruce ex Griseb.) C.V.Morton
Flower: oil gland at the calyx present; colour petal pinkish/yellow pale; indumentum locule of the anther glabrescent/pilose/sparsely; style posterior slightly ...
[12]
Banisteriopsis caapi (Spruce ex Griseb.) C.V.Morton
Elevation range: 100–2200 m a.s.l. Cultivated in Colombia. Native to Colombia. Colombian departments: Amazonas, Antioquia, Caquetá, Cauca, Chocó, Cundinamarca, ...
[13]
Dated Phylogeny of Banisteriopsis (Malpighiaceae) Suggests an ...
Although the center of diversity for Banisteriopsis is proposed to be in the Cerrado of central Brazil, B. caapi occurs in the northwestern Amazon (Brazil, ...
[14]
[EPUB] Of shrub, cactus, vine and toad: psychedelic species of conservation ...
Sep 29, 2025 · Ecology and biology of ayahuasca vine Ayahuasca vine (Banisteriopsis caapi (Spruce ex Griseb.) C.V.Morton, 1931) is a woody, evergreen tropical ...
[15]
What About the Conservation of the Ayahuasca Vine? | Chacruna
Jul 15, 2022 · Banisteriopsis caapi is a forest vine, often found climbing on other trees for support. It has smooth, brown bark and dark green, large, pointed ...<|separator|>
[16]
Increased clonal growth in heavily harvested ecosystems failed to ...
Aug 14, 2023 · The long-term population growth rates of B. caapi populations under high harvest pressure were projected to decline at a rate of 1.3% whereas ...
[17]
The mitogenomic landscape of Banisteriopsis caapi (Malpighiaceae ...
Jul 1, 2024 · Banisteriopsis caapi samples morphological identified as the nodeless Tucunacá ethnovariety were sourced from cultivation environment ...
[18]
[PDF] 10. The Scientific Investigation of Ayahuasca
The concentrations of alkaloids reported in Banisteriopsis caapi range from 0.05 % dry weight to 1.95 % dry weight; in Psychotria, the concentration of ...
[19]
Composition, Standardization and Chemical Profiling of ... - NIH
The alkaloid content of B. caapi was determined previously by GC/MS ... New alkaloids from Banisteriopsis caapi. Phytochemistry. 1976;15:1559–1560 ...
[20]
[PDF] Assessment of environmental condition and drying process of the ...
May 6, 2021 · Objective: To evaluate the causes of variations in alkaloids concentrations of Ayahuasca prepared with fresh and dehydrated plants from ...
[21]
New Insights into the Chemical Composition of Ayahuasca
Apr 1, 2022 · (10) Generally, the main β-carboline alkaloids that are present in the drink are harmine (1) and (+)-tetrahydroharmine (2), while harmaline (3) ...
[22]
A rapid analytical strategy for the determination of ayahuasca ...
Detection of ayahuasca alkaloids by UHPLC-MS/MS. •. A simple, rapid and useful workflow to estimate the concentration of psychoactive compounds in seized ...
[23]
A Fully Validated LC-MS Quantitation Method for Psychoactive ...
In this paper, we have developed and fully validated a single LCMS method to quantify six psychedelics, DMT, 5-MeO-DMT, THH, harmine, harmaline, and tryptamine, ...
[24]
Toxicokinetics and Toxicodynamics of Ayahuasca Alkaloids N,N ...
... alkaloids harmine, harmaline, and tetrahydroharmine (THH). As such, the main ... viridis ranges from 0.1% to 0.66% dry weight, while the β-carboline alkaloids ...
[25]
Phytochemical Analyses of Banisteriopsis Caapi and Psychotria Viridis
Aug 9, 2025 · The DMT content in Psychotria viridis bush and of β-carboline alkaloids in Banisteriopsis caapi vine ranges from 3-9.5 or 0.05%-1.95% mg/g dry ...
[26]
Composition, standardization and chemical profiling of ...
Apr 21, 2010 · HPLC was employed to profile the alkaloidal and non-alkaloidal components of the aqueous extract of B. caapi. The extracts were simultaneously ...
[27]
an overview of Ashéninka ethnomedicine (Western Amazonia) - PMC
Nov 10, 2006 · The qualitative comparison between ethnobotanical records among both ethnic groups substantiates that Shipibo knowledge is massively adopted ...
[28]
Asháninka medicinal plants: a case study from the native community ...
Aug 13, 2010 · The present study assesses the state of traditional medicinal plant knowledge in the community and compares the local pharmacopoeia with the one from a related ...Missing: evidence | Show results with:evidence
[29]
Traditional Use of Banisteriopsis caapi Alone and Its Application in a ...
Sep 27, 2020 · The research began with a field trip to Awajún territory to explore the indigenous use of purgahuasca as an initiation rite.
[30]
Traditional Use of Banisteriopsis caapi Alone and Its Application in a ...
It is a decoction of the vine Banisteriopsis caapi alone, whose use is traditional among the Awajún and other ethnic groups in Peru.
[31]
[PDF] Unraveling the Mystery of the Origin of Ayahuasca - NEIP
The vine *Banisteriopsis caapi* was first used alone, then combined with *Psychotria viridis* in Iquitos and *Diplopterys cabrerana* around the upper Putumayo ...
[32]
[PDF] 1. Indigenous and mestizo use of ayahuasca. An overview
The point of dispersion of the use of Banisteriopsis caapi is not known, or when this might have happened. The origin of its use may forever remain a mystery.
[33]
http://ciencia.udv.org.br/wp-content/uploads/2019/04/Global_Networks_2009_Tupper.pdf
[34]
The Globalization of Ayahuasca Shamanism and the Erasure of ...
Sep 15, 2016 · This paper focuses on some of the problematic aspects of western engagement with indigenous spiritual traditions.Missing: modern criticisms
[35]
Is ayahuasca tourism 'cultural appropriation'?
Feb 2, 2018 · The authors raise two concerns. Firstly, vulnerable Western tourists are being exploited by fake shamans. Secondly, rapacious Western tourists ...Missing: modern scholarly
[36]
(PDF) Charlatans, seekers, and shamans: the ayahuasca boom in ...
(Buchillet 2004). The concept of dark shamanism is extremely important for the vast majority of. indigenous peoples in Amazonia that engage in ayahuasca ...
[37]
Ayahuasca: A review of historical, pharmacological, and therapeutic ...
The key ingredients of an ayahuasca brew are Banisteriopsis caapi, a vine also referred to as ayahuasca independently, and a plant containing N,N ...
[38]
A Look at the Ayahuasca Brewing Process: Unveiling Ancient ...
Sep 18, 2024 · The crushed vine and leaves are combined with water in a large pot. The mixture is then boiled for several hours, sometimes up to 12 hours, to ...
[39]
Ayahuasca Diet Guide: Pre-Ceremony, During, and Post-Ceremony ...
Nov 7, 2024 · It is also recommended to fast for several hours before the ceremony to reduce the heaviness of the purge that ayahuasca induces. The diet and ...
[40]
Monoamine Oxidase Inhibition by Plant-Derived β-Carbolines
May 2, 2022 · An important class of antidepressant medications provoke a complete and irreversible inhibition of MAO-A/B, and such complete inhibition is ...Missing: IC50 | Show results with:IC50
[41]
Altered states, alkaloids, and catatonia: Monoaminoxidase inhibitors ...
Dec 5, 2022 · Harmine is another one of the many MAO inhibitors described in the literature and is a high-potency reversible inhibitor of MAO-A: IC50 = 0.0041 ...<|separator|>
[42]
Activities of extract and constituents of Banisteriopsis caapi relevant ...
The value of 19.2 mg harmine per gram lyophilised extract is comparable with values obtained in a previous study on several samples where the mean value was ...
[43]
Banisteriopsis caapi, a unique combination of MAO inhibitory and ...
Harmaline (6) and harmine (7) showed potent in vitro inhibitory activity against recombinant human brain monoamine oxidase (MAO)-A and -B enzymes (IC50 2.5 and ...Missing: IC50 reversible
[44]
from ayahuasca to synthetic combinations of DMT and MAO inhibitors
Sep 10, 2024 · Whereas harmine and moclobemide are reversible MAO-A inhibitors, certain propargyl compounds form a covalent bond with the enzyme, rendering it ...Missing: IC50 | Show results with:IC50
[45]
Banisteriopsis caapi, a unique combination of MAO inhibitory ... - NIH
Tests for MAO inhibition using liver homogenate showed that B. caapi stem extract and harmine showed a concentration-dependent inhibition of MAO-A, and an ...Missing: IC50 reversible
[46]
Binding of beta-carbolines and related agents at serotonin (5-HT(2 ...
The beta-carbolines were found to bind with modest affinity at 5-HT(2A) receptors, and affinity was highly dependent upon the presence of ring substituents and ...
[47]
Harmine augments electrically evoked dopamine efflux in ... - PubMed
Oct 17, 2012 · Harmine is an inhibitor of monoamine oxidase A (MAO-A) and interacts in vitro with several pharmacological targets which modulate dopamine (DA) ...
[48]
Stimulatory effect of harmane and other β-carbolines on locus ...
Harmane, harmaline and norharmane are β-carboline related compounds which have been proposed to be endogenous ligands for imidazoline receptors.
[49]
Harmine stimulates proliferation of human neural progenitors - NIH
Dec 6, 2016 · Our findings show that harmine enhances proliferation of hNPCs and suggest that inhibition of DYRK1A may explain its effects upon proliferation in vitro and ...
[50]
A Phase 1 single ascending dose study of pure oral harmine in ...
Sep 20, 2024 · The mechanisms for nausea and vomiting are uncertain and may include direct effects of harmine on the CNS and/or on the intestine via its ...
[51]
Human pharmacology of ayahuasca: subjective and cardiovascular ...
Diastolic blood pressure showed a significant increase at the high dose (9 mm Hg at 75 min), whereas systolic blood pressure and heart rate were moderately and ...
[52]
Adverse effects of ayahuasca: Results from the Global ... - NIH
Nov 16, 2022 · The main physical side effects are nausea, vomiting, and diarrhoea, but in traditional settings those effects are considered part of the ...
[53]
Pharmacokinetics of Hoasca alkaloids in healthy humans
For this reason it is orally inactive. Harmine and harmaline allow the oral activity of DMT by temporarily inhibiting the activity of MAO, and the resulting ...
[54]
from ayahuasca to synthetic combinations of DMT and MAO inhibitors
THH may also contribute to net MAO inhibition despite its weaker affinity as compared to harmine and harmaline [10, 64]. The B. caapi β-carbolines are ...
[55]
Ayahuasca: A review of historical, pharmacological, and therapeutic ...
Oct 2, 2023 · Ayahuasca's psychoactive effects are thought to be mediated primarily by 5-HT2A receptor activation, although DMT also binds to other serotonin ...
[56]
Behavioral profile of constituents in ayahuasca, an Amazonian ...
Ayahuasca is a psychoactive plant mixture typically composed of the β-carboline-rich Banisteriopsis caapi vine and the hallucinogenic plant Psychotria viridis.Missing: ethnobotany | Show results with:ethnobotany
[57]
Rapid antidepressant effects of the psychedelic ayahuasca in ...
Jun 15, 2018 · We found evidence of rapid antidepressant effect after a single dosing session with ayahuasca when compared with placebo. Depression severity ...
[58]
A placebo-controlled study of the effects of ayahuasca, set and ...
Mar 10, 2021 · This naturalistic observational study was designed to assess whether mental health changes were produced by ayahuasca or by set and setting.
[59]
https://journals.plos.org/mentalhealth/article?id=10.1371/journal.pmen.0000097
[60]
Ayahuasca: Uses, Side Effects, Risks and Safety - WebMD
Oct 21, 2024 · When you use it, it can alter your ability to think, blur your sense of time, and heighten your emotions. You might also hallucinate, which is ...What's An Ayahuasca Retreat? · Ayahuasca Effects · Ayahuasca Harm Reduction
[61]
Ayahuasca and the traveller: A scoping review of risks and possible ...
Ayahuasca use is associated with a risk of both psychiatric and non-psychiatric events including hallucinations, agitation or aggression, vomiting, seizure, and ...
[62]
Effects of ayahuasca on mental health and quality of life in naïve users
Mar 5, 2020 · Data from observational studies suggest that ayahuasca and its active ingredient DMT may have anxiolytic properties. Furthermore, it has not ...
[63]
Banisteriopsis Caapi - an overview | ScienceDirect Topics
Banisteriopsis Caapi is a psychotropic plant vine native to the Amazon rainforest, traditionally used in indigenous pharmacopoeias to induce visionary states ...
[64]
Banisteriopsis caapi, a Forgotten Potential Therapy for Parkinson's ...
Banisteriopsis caapi, a liana indigenous to the Amazon basin with metagnomigenic properties and possible anti‐depressant effects is one of the natural sources ...Missing: stems | Show results with:stems
[65]
Richard Evans Schultes: Ayahuasca Studies in the Amazon
Richard Evans Schultes lived with more ayahuasca-using tribes than anyone else, documenting their use of the brew over the 17 years he spent in the Amazon.
[66]
The Amazonian Travels of Richard Evans Schultes
Richard Evans Schultes – ethnobotanist, taxonomist, writer and photographer – is regarded as one of the most important plant explorers of the 20th century.
[67]
Reassessing the Cultural and Psychopharmacological Significance ...
Aug 9, 2025 · This article reviews the psychopharmacological literature on B. caapi in light of recent ethnographic work conducted among the Piaroa of ...
[68]
Antidepressant Effects of Ayahuasca: a Randomized Placebo ...
Common effects of Ayahuasca include sedation, gastrointestinal distress, changes of spatiotemporal scaling, dissociation, sense of well-being, insights, ...
[69]
The Psychedelic State Induced by Ayahuasca Modulates the Activity ...
Feb 18, 2015 · Self-oriented mental activity has been consistently linked to the Default Mode Network (DMN), a set of brain regions more active during rest ...
[70]
Neural Network Modulation of Ayahuasca: A Systematic Review of ...
Mar 20, 2023 · In general, the results presented were supported by different neuroimaging tools, allowing the verification of the brain regions affected during ...
[71]
Ayahuasca Treatment Outcome Project (ATOP): One-Year Results ...
Participants in the study improved on outcomes related to substance use severity and mental wellness 1 year after discharge. They also reported the experience ...
[72]
Psychedelics for Substance Use Disorders - Psychiatry Online
Mar 6, 2025 · One study investigated the impact of a 4-day ayahuasca retreat on substance use and psychological functioning among 12 participants (18). The ...
[73]
Ayahuasca-assisted meaning reconstruction therapy as an early ...
Sep 1, 2025 · Preliminary evidence suggests that ayahuasca may alleviate severe grief symptoms. This three-arm, sequentially allocated, open-label study ...
[74]
Development of a physiologically based pharmacokinetic model of ...
Aug 21, 2025 · The models account for multiple routes of administration (intraperitoneal, oral, intravenous, and buccal) and integrate harmine's inhibition of ...
[75]
Banisteriopsis caapi extract: Implications for neuroinflammatory ...
Jan 30, 2025 · The Banisteriopsis caapi extract consists of harmine, harmaline, and tetrahydroharmine (THH); which inhibit the isoforms of monoamine ...
[76]
Overcoming the clinical challenges of traditional ayahuasca - Frontiers
Nov 26, 2023 · Although ayahuasca ingestion is considered safe, its pharmacokinetics/pharmacodynamics and tolerability profile pose some challenges and may ...
[77]
Ayahuasca's therapeutic potential: What we know – and what not
The most consistent evidence refers to depression. However, various studies suggest that ayahuasca may comprise therapeutic benefits in other health conditions.Review · Abstract · Introduction
[78]
The pharmacological interaction of compounds in ayahuasca
The right combination, including tyramine and MAOIs, can potentially lead to hypertensive crisis and other typical adverse effects. ... The alkaloids of ...
[79]
Ayahuasca, dimethyltryptamine, and psychosis: a systematic review ...
Feb 23, 2017 · He arrived at the emergency department, brought by the police ... (2008) Ayahuasca and psychosis. Br J Psychiatry (eLetter), 3 ...
[80]
Psychosis induced by abuse of ayahuasca: a case report
Ayahuasca-induced psychosis could be related to serotonin and dopamine system interactions, (,, and have been described as unusual when ayahuasca is used in ...
[81]
Ayahuasca and Dimethyltryptamine Adverse Events and Toxicity ...
Data showed that ayahuasca or DMT is generally safe; however, some adverse human events have been reported. Animal models using higher doses of ayahuasca have ...
[82]
Ayahuasca-Induced Serotonin Syndrome: Risks, Mechanisms, and ...
Although isolated fatalities have been reported, insufficient data preclude causality. Common adverse effects include nausea, vomiting, and diarrhea—likely due ...<|separator|>
[83]
Ayahuasca-induced serotonin syndrome: About a case
The therapeutic and toxic effects of this artisanal concoction are still under study, posing a pharmacological challenge as its toxicological properties are not ...
[84]
Risk assessment of ayahuasca use in a religious context
Oct 30, 2020 · Toxicology Investigators Consortium (ToxIC) Serotonin toxicity: associated agents and clinical characteristics. J Clin Psychopharmacol. 2019 ...
[85]
Ayahuasca - Alcohol and Drug Foundation
Jun 6, 2025 · It is combined with the Banisteriopsis caapi vine, which contains a monoamine oxidase inhibitor (MAOI) and prevents the rapid breakdown of DMT.
[86]
MAPS - MAOI Contraindications [related to Ayahuasca]
Contraindications to the use of MAOIs include severe liver and kidney impairment, severe or frequent headache, uncontrolled hypertension, cardiovascular ...Missing: caapi | Show results with:caapi
[87]
Long-term ayahuasca use is associated with preserved global ...
May 23, 2024 · Short and long-term ayahuasca consumption does not seem to alter human cognition, while long-term use seems to be associated with improvements in aspects of ...Missing: dependence 2020-2025
[88]
A Longitudinal Study | PLOS One - Research journals
In conclusion, we found no evidence of psychological maladjustment, mental health deterioration or cognitive impairment in the ayahuasca-using group.<|separator|>
[89]
Ayahuasca Addiction: What It Is, Effects & Risks
Mar 6, 2025 · However, psychological dependence is possible. Some people may become fixated on the emotional or spiritual revelations they believe ayahuasca ...
[90]
[PDF] CONVENTION ON PSYCHOTROPIC SUBSTANCES, 1971
2. The United Nations Conference for the Adoption of a Protocol on Psychotropic Substances met in Vienna from 1 1 January to 21 February 1971. 3 ...Missing: caapi | Show results with:caapi
[91]
Ayahuasca's International Legal Status | ADF - ICEERS
No plant is subject to international control under the Convention on Psychotropic Substances of 1971. However, the treaty does list certain active ingredients.
[92]
[PDF] Hoasca 1971 Convention Legal Brief - ICEERS
Schaepe's opinion was clear: “No plants (natural materials) containing. DMT are at present controlled under the 1971 Convention on. Psychotropic Substances.
[93]
Convention on Psychotropic Substances of 1971 - UNTC
Ayahuasca is used by certain Amazon ethnic groups in magical and religious rites and in rites of initiation into adulthood; San Pedro is used in magical rites ...
[94]
[PDF] United Nations Declaration on the Rights of Indigenous Peoples
1. Indigenous peoples have the right to the rec- ognition, observance and enforcement of treaties, agreements and other constructive arrangements concluded ...
[95]
Ayahuasca: From the Amazon to the Global Village
Dec 18, 2015 · Indigenous peoples in the Amazon have used ayahuasca for centuries as a remedy for physical and psychological health, and to ensure the life and wellbeing of ...
[96]
Ayahuasca's Legal Landscape in the US - Recovered.org
Apr 24, 2025 · Ayahuasca's legal status in the United States remains a blend of federal prohibitions, patchwork state or municipal stances, and narrow religious exemptions.Ayahuasca · Legal status · Exemptions · State regulations
[97]
Legal Status of Ayahuasca | Drug Policy Facts
Feb 21, 2025 · The UDV is now legally allowed to drink ayahuasca (which contains the controlled substance DMT) in their ceremonies here in the US.
[98]
Legal Guide to Decriminalized Natural Medicine in Colorado
May 29, 2023 · Colorado is the first state to decriminalize natural psychedelics for personal and communal use. Natural psychedelics remain illegal under federal law.Missing: Oregon | Show results with:Oregon<|control11|><|separator|>
[99]
Is Ayahuasca Legal? Laws and Status by Country in 2025
Some nations allow ayahuasca for religious or ceremonial use, while others strictly ban it due to its psychoactive properties.
[100]
Psychedelics Legalization & Decriminalization Tracker
As of July 14, 2025, neither bill has been signed into law. ... In 2019, with the passage of Initiative 301 Denver became the first U.S. city to deprioritize law ...
[101]
Reassessing ayahuasca regulation in Brazil: strategic framing and ...
Oct 14, 2024 · The DEA and the State Department had been pressuring the Brazilian government to make ayahuasca illegal, in order to support its own domestic ...
[102]
Legal Status Of Ayahuasca by Country - HighFlyers
Oct 25, 2024 · In France and the UK, ayahuasca is classified as an illegal substance and carries heavy penalties for possession or distribution.
[103]
Ayahuasca is gaining ground in Europe despite the legal loophole
Jul 22, 2025 · However, in most cases, the courts have dismissed the cases after finding no evidence of a crime, recognizing that ayahuasca is not regulated ...
[104]
Is Banisteriopsis caapi illegal to import?
Nov 21, 2024 · In the U.S., the legal status of Banisteriopsis caapi is complex. The plant itself isn't specifically listed as illegal. However, ayahuasca ...
[105]
United States of America | Legal situation of ayahuasca - ICEERS
Jan 25, 2022 · Ayahuasca (which contains DMT) is illegal to import, consume, possess, sell, and distribute in the United States.Missing: analog | Show results with:analog
[106]
Banisteriopsis caapi - Electric Veg
Jun 22, 2023 · Banisteriopsis caapi is a perennial vine native to the Amazon rainforest known for its role in South American ayahuasca ceremonies. These ...
[107]
Banisteriopsis caapi Propagation 101 - Shaman Australis Forums
Jan 24, 2011 · Take a piece of vine and cut it into "T" sections like so: Simply place these cuttings in your prefered potting medium, In my case I use coco peat but any ...growing Banisteriopsis caapi - Ethnobotany - The CorroboreeBanisteriopsis caapi Cultivation - Shaman Australis ForumsMore results from www.shaman-australis.comMissing: seeds | Show results with:seeds
[108]
Failproof way to propagate Banisteriopsis caapi - Share the Seeds
Apr 28, 2019 · The easiest way to bring a cutting and have it grow is to take one that's already rooted. These vines tend to creep on the ground and send aerial roots.Banisteriopsis caapi propagationB. caapi cuttings and death from overwateringMore results from sharetheseeds.meMissing: methods | Show results with:methods
[109]
B. Caapi Propagation Questions - The Ethnobotanical Garden
I have the cutting in a humidity dome which I spray multiple times a day and it has a fluorescent grow light. I used a semi softwood cutting. We also have humid ...
[110]
How to Germinate Banisteriopsis Caapi Seeds - World Seed Supply
Aug 19, 2014 · The real trick is getting fresh seed. Banisteriopsis caapi seed harvest generally occurs in October or November. It can range a bit depending on yearly climate.Missing: methods | Show results with:methods
[111]
https://www.magicgardenseeds.com/Ayahuasca-Yage-Banisteriopsis-caapi-seeds
[112]
Banisteriopsis caapi Yage, Ayahuasca, Caapi PFAF Plant Database
It prefers moist soil. UK Hardiness Map US Hardiness Map. Synonyms ... Native Range. SOUTHERN AMERICA: Venezuela, Brazil, Bolivia, Colombia, Ecuador ...
[113]
How To Grow Banisteriopsis Caapi From Seed
Feb 1, 2022 · Cuttings can be rooted into soil, just like cannabis clones, where they will flourish into fully formed vines later on.
[114]
growing Banisteriopsis caapi - Ethnobotany - The Corroboree
Feb 26, 2002 · They thrive in hot humid conditions with rainforest lighting conditions... when in optimal conditions these things can grow several feet in a ...Banisteriopsis caapi Propagation 101 - Shaman Australis ForumsBanisteriopsis caapi cultivation notes and discussion - EthnobotanyMore results from www.shaman-australis.com
[115]
https://toptropicals.com/catalog/uid/banisteriopsis_caapi.htm
[116]
Banisteriopsis Caapi - an overview | ScienceDirect Topics
Banisteriopsis caapi is a South American hallucinogenic vine in the Malpighiaceae plant family, and is well recognised as a main ingredient of the famous sacred ...
[117]
Increased clonal growth in heavily harvested ecosystems failed to ...
Aug 14, 2023 · Further, increased use or harvest pressure on B. caapi populations are expected to force harvesters further into the Amazon rainforest which may ...
[118]
Global ayahuasca trend drives deforestation in Brazil's Acre state
Dec 22, 2021 · The growing popularity and increased commercialization of ayahuasca, a psychoactive brew, may be harming the Amazon forest where its two key ...
[119]
Of shrub, cactus, vine and toad: psychedelic species of conservation ...
While B. caapi is not listed or assessed by the International Union for Conservation of Nature (IUCN), there is anecdotal and now academic evidence that its ...
[120]
Shamans Fear the Extinction of Ayahuasca in the Amazon
Sep 3, 2024 · Shipibo-Conibo leaders are concerned about over-harvesting of ayahuasca plants, high demand from foreign countries, pharmaceutical extraction, ...Missing: sustainability | Show results with:sustainability
[121]
Tourist boom for ayahuasca a mixed blessing for Amazon
Jan 24, 2017 · Short supply of plant has led to uptake in commercial planting, use of dangerous alternatives and fears of deforestation.